FORTE, DORIAN
 Distribuzione geografica
Continente #
AS - Asia 2.886
NA - Nord America 2.332
EU - Europa 1.738
AF - Africa 161
SA - Sud America 160
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.284
Nazione #
US - Stati Uniti d'America 2.282
VN - Vietnam 816
SG - Singapore 722
CN - Cina 693
IT - Italia 516
GB - Regno Unito 273
DE - Germania 201
SE - Svezia 193
HK - Hong Kong 181
IN - India 125
BR - Brasile 112
KR - Corea 111
FR - Francia 101
NL - Olanda 77
FI - Finlandia 76
IE - Irlanda 65
RU - Federazione Russa 54
TG - Togo 47
CI - Costa d'Avorio 39
JP - Giappone 39
CA - Canada 32
BG - Bulgaria 30
TR - Turchia 29
ZA - Sudafrica 29
BE - Belgio 25
JO - Giordania 21
ID - Indonesia 19
TH - Thailandia 19
TW - Taiwan 19
EE - Estonia 18
AT - Austria 17
PH - Filippine 17
UA - Ucraina 17
BD - Bangladesh 16
CH - Svizzera 16
IQ - Iraq 14
PL - Polonia 14
ES - Italia 13
IR - Iran 12
MX - Messico 12
AR - Argentina 11
EC - Ecuador 11
NG - Nigeria 10
CL - Cile 9
LT - Lituania 8
PK - Pakistan 8
SC - Seychelles 8
VE - Venezuela 6
EG - Egitto 5
MA - Marocco 5
MY - Malesia 5
TN - Tunisia 5
UY - Uruguay 5
AU - Australia 4
PT - Portogallo 4
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GA - Gabon 2
GH - Ghana 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MD - Moldavia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.284
Città #
Singapore 512
Ashburn 329
Chandler 245
Southend 212
Ho Chi Minh City 192
San Jose 183
Hong Kong 168
Hanoi 156
Hefei 156
Fairfield 125
Bologna 110
Dong Ket 105
Seoul 100
Beijing 92
Santa Clara 85
Ann Arbor 81
Wilmington 69
Dublin 65
Princeton 60
Milan 58
Seattle 55
Houston 54
Helsinki 52
Lomé 47
Woodbridge 47
Boardman 46
Cambridge 46
Dallas 42
Abidjan 39
Council Bluffs 39
Lauterbourg 35
New York 34
Cornaredo 32
Los Angeles 32
Tokyo 28
Sofia 27
Haiphong 26
Da Nang 25
Hyderabad 24
Munich 24
Redmond 24
Turin 24
Bremen 23
Brussels 23
Berlin 22
Rome 21
Westminster 21
Amman 20
Buffalo 20
Nanjing 20
Burdur 18
Bengaluru 17
Frankfurt am Main 17
Jinan 17
Redondo Beach 17
Lappeenranta 15
Padova 15
Shenyang 15
São Paulo 15
Shanghai 14
Jakarta 13
Johannesburg 13
Nuremberg 13
San Diego 13
Hangzhou 12
London 12
Biên Hòa 11
Guangzhou 11
Abeokuta 10
Changsha 10
Montreal 10
Redwood City 10
Toronto 10
Bern 9
Florence 9
Medford 9
Norwalk 9
Saint Petersburg 9
Stockholm 9
Taiyuan 9
Tianjin 9
Warsaw 9
Amsterdam 8
Falkenstein 8
Fremont 8
Orem 8
Quận Bình Thạnh 8
San Francisco 8
Shenzhen 8
Turku 8
Boston 7
Hải Dương 7
Nanchang 7
Paris 7
Shijiazhuang 7
Vienna 7
Atlanta 6
Bình Phước 6
Chennai 6
Des Moines 6
Totale 4.594
Nome #
Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis 310
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 275
Circulating calreticulin is increased in myelofibrosis: Correlation with interleukin-6 plasma levels, bone marrow fibrosis, and splenomegaly 258
Disease-specific derangement of circulating endocannabinoids and n-acylethanolamines in myeloproliferative neoplasms 226
CIRCULATING PLATELET AND MEGAKARYOCYTE-DERIVED MICROPARTICLES OF JAK2V617F MUTATED PATIENTS WITH MYELOFIBROSIS ARE DISREGULATED: A NOVEL LIQUID BIOPSY TOOL OF RESPONSE TO RUXOLITINIB? 218
CIRCULATING CD34+ STEM/PROGENITOR CELLS FROM TRIPLE NEGATIVE PATIENTS WITH MYELOFIBROSIS SHOW DIFFERENT NUMBER, GENE EXPRESSION PROFILE AND IN VITRO RESPONSE TO INFLAMMATORY STIMULI AS COMPARED WITH THE JAK2(V617F) MUTATED COUNTERPARTS 212
Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive disease 209
Mobilized Peripheral Blood versus Cord Blood: Insight into the distinct role of proinflammatory cytokines on survival, clonogenic ability, and migration of CD34+ cells 204
STUDIO DELLA FUNZIONE E DEL PROFILO DEI MICRORNA IN MICROPARTICELLE CIRCOLANTI ISOLATE DA PAZIENTI ‘TRIPLI NEGATIVI’ E JAK2V617F MUTATI CON MIELOFIBROSI 201
Circulating Platelet Vs Megakaryocyte-Derived Microparticles Identify Myelofibrosis Patients with JAK2V617F Mutation, High Disease Burden and Ruxolitinib Response 198
The more, the better: "Do the right thing" for natural killer immunotherapy in acute myeloid leukemia 195
Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis 192
Crucial factors of the inflammatory microenvironment (IL-1β/ TNF-α/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study 185
TOWARD THE IDENTIFICATION OF A MICRORNA-BASED SIGNATURE OF CIRCULATING MICROPARTICLES FROM TRIPLE NEGATIVE AND JAK2(V617F) MUTATED PATIENTS WITH MYELOFIBROSIS 184
Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells 184
Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy 184
The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study 183
Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia 181
The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling 181
Platelet lysate enhances the therapeutic activity of Adipose Derived Mesenchymal stromal cells isolated from Crohn disease patients in a novel Mouse model of Colitis 181
Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis 179
Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells (Front. Oncol, (2020), 10, (1225), 10.3389/fonc.2020.01225) 178
Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability 176
The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling 170
Crucial Factors of the Inflammatory Microenvironment (IL-1 beta/TNF-alpha/TIMP-1) Promote Maintenance of the Malignant Hemopoietic Clone of Myelofibrosis By Stimulating the in Vitro Survival/Proliferation/Migration of Circulating CD34+ stem/Progenitor Cells 168
The “vesicular intelligence” strategy of blood cancers 166
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells 162
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 159
INFLAMMATORY PATHWAYS IN THE BONE MARROW: ROLE OF TIMP-1 IN HEMATOPOIETIC STEM/PROGENITOR CELLS AND LEUKEMIA 146
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches 144
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets 144
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis 142
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis 135
The Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Regulates the Function and Migration of Leukemic Blasts through CD63/PI3K/AKT/P21 Axis 134
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data 134
Emerging bone marrow microenvironment‐driven mechanisms of drug resistance in acute myeloid leukemia: Tangle or chance? 133
KAT2A complexes ATAC and SAGA play unique roles in cell maintenance and identity in hematopoiesis and leukemia 117
Updates on the hematologic tumor microenvironment and its therapeutic targeting 113
Bone marrow mesenchymal stromal cells support translation in refractory acute myeloid leukemia 106
IDENTIFICATION OF POLYCYTHEMIA VERA-SPECIFIC BIOMARKERS OF OUTCOME BY NOVEL MULTIDIMENSIONAL ANALYSIS APPROACHES 96
Single-Cell Metabolic Profiling Integrated with Extracellular Vesicle Analysis Reveals Novel Metabolic Vulnerabilities and Prognostic Biomarkers in Acute Myeloid Leukemia 74
Clinical Implications of Plasma-Derived Extracellular Vesicles in Myeloproliferative Neoplasms: Unveiling Inflammatory Potential and Biomarkers for Cancer Treatment 71
Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia 65
Extracellular Vesicle-Based Liquid Biopsy Shows Clinical Relevance and Reveals Links with Single-Cell Metabolic Signature in Acute Myeloid Leukemia 65
PICK A WORD: HOW EXTRACELLULAR VESICLES DICTATE THE NORMAL AND LEUKEMIC HEMATOPOIETIC LANDSCAPE 44
Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor 40
Leukemic Stem Cells Co-Opt Normal Bone Marrow Niches As a Source of Energy and Antioxidant Defence 26
null 2
Totale 7.450
Categoria #
all - tutte 19.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021239 0 0 0 0 0 0 0 0 0 19 20 200
2021/2022692 26 28 46 60 60 27 14 40 28 73 156 134
2022/2023897 115 139 52 120 51 79 15 43 156 21 56 50
2023/2024342 22 42 14 49 22 55 19 22 17 26 38 16
2024/20251.265 83 106 112 87 124 69 88 69 76 102 96 253
2025/20263.077 332 375 245 216 289 156 313 180 732 239 0 0
Totale 7.450